Applied Molecular Transport to Present at Upcoming June Investor Conferences
06/02/2022 - 08:00 AM
SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced its participation in fireside chats at the following investor conferences:
Event: Jefferies Global Healthcare ConferencePresentation Date & Time: Thursday, June 9, 2022, at 8:30 a.m. ET Location: New York, New YorkPresenter: Tahir Mahmood, Ph.D., chief executive officer and co-founder
Event: JMP Securities 2022 Life Sciences ConferencePresentation Date & Time: Wednesday, June 15, 2022, at 1:00 p.m. ET Location: New York, New YorkPresenters: Shawn Cross, president and chief operating officer, and Bittoo Kanwar, M.D., chief medical officer
Live webcasts will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events . Archived replays will be available for 30 days following the events.
About Applied Molecular Transport Inc. AMT is a clinical-stage biopharmaceutical company developing novel oral biologic product candidates, by leveraging its technology platform to design biologic product candidates in patient friendly oral dosage forms. AMT’s product candidates are designed to precisely target the relevant pathophysiology of disease. AMT’s proprietary technology platform is incorporated in its product candidates, exploiting existing natural cellular trafficking pathways to drive the active transport of diverse therapeutic modalities across the IE barrier. Active transport is an efficient mechanism that utilizes the cell’s own machinery to transport materials across the IE barrier.
AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com .
Investor Relations Contact: achang@appliedmt.com
Media Contacts: asantos@wheelhouselsa.com
Aljanae Reynolds
Applied Molecular Transport Inc
AMTI Rankings
N/A Ranked by Stock Gains
AMTI Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
About AMTI
applied molecular transport is developing a pipeline of transformative, targeted oral biological therapeutics that promise to redefine the future of biopharmaceuticals. our deep scientific foundations in mucosal immunology and microbiome-epithelial interfaces have led to the development of powerful technology platforms that are fueling a unique pipeline of first-in-class molecules to treat a wide range of grievous diseases. our oral biopharmaceutical products mimic the biology of microbial and other natural processes that modulate health and disease via mucosal immunology pathways. our targeted therapeutics are directed to the right location to intercept disease at the point of origin of dysregulation. we are advancing a pipeline of targeted oral biological therapeutics to treat autoimmune, inflammation and other diseases, including those associated with cancer, metabolic and hepatologic disorders. our overriding patient-centric goal is to open new biological possibilities based on nov
